In the LinkedOmics dataset, the high expression of IGF2BP1, IGF2BP2, and IGF2BP3 was significantly associated with the poor overall survival of pancreatic cancer patients (Fig. 3a). Here, IGF2BP1 is linked to pancreatic neoplasm.